Browse studies

Find your next paid study

27,365 recruiting studies available now

Code of Respect (X-CoRe): a Randomized Controlled Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen

The purpose of this study is to examine the efficacy of Code of Respect (X-CoRe) multi-level sexual assault (SA) and harassment (SH) prevention program in impr…

Sexual AssaultSexual Harassment

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT06101056

Phase 1

A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients

The goal of Phase 1a of this clinical research study is to find the highest tolerable dose of revumenib that can be given in combination with cytarabine, dauno…

Pediatric Acute Leukemia

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07052994

Observational

Sensorimotor Basis of Speech Motor Learning and Retention

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with …

Speech

Estimated

~$10 – $6,250

Yale UniversityNCT06467305

Observational

Optimizing Post-Stroke Gait Symmetry: Integrating Mechanical Constraints and Sensory Feedback to Enhance Paretic Leg Propulsion

This single-session study aims to evaluate a novel gait training protocol that integrates mechanical constraints and sensory feedback to enhance paretic leg pr…

StrokeSplit-belt TreadmillResistance Exercise+2 more

Estimated

~$10 – $6,250

The University of Texas Medical Branch, GalvestonNCT07087769

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma: A Study to Develop Evidence of Effectiveness for the Centers for Medicare and Medicaid Services (CMS)

Multiple myeloma (MM) is the second most common hematologic malignancy in adults. The current standard of care for MM patients fit to undergo high dose conditi…

Multiple Myeloma

Estimated

~$10 – $1,125

Center for International Blood and Marrow Transplant ResearchNCT03127761

Observational

Prehabilitation in Patients With Multiple Myeloma Receiving CAR-T Therapy

This clinical trial evaluates whether prehabilitation with aerobic and resistance exercise improves physical fitness and quality of life outcomes in older pati…

Recurrent Multiple MyelomaRefractory Multiple Myeloma

Estimated

~$10 – $6,250

Mayo ClinicNCT07045727

Phase 1

A Global, Phase 1/2, Open-Label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants With Propionic Acidemia

This 3-part, Phase 1/2 study is designed to characterize the safety, tolerability, and pharmacological activity (as assessed by biomarker measurements) and to …

Propionic Acidemia

Estimated

~$10 – $8,750

ModernaTX, Inc.NCT04159103

Phase 2

Adjuvant Tirzepatide Plus Standard of Care Endocrine Therapy in Patients With Obesity or Overweight Who Have Hormone Receptor-positive, HER2-negative, Node-positive Early Breast Cancer, With Molecular Residual Disease (MRD), as Determined by Circulating Tumor DNA (ctDNA)

This trial aims to asses if tirzepatide-induced weight loss will lead to metabolic and hormonal changes in hormone receptor-positive (HR+), human epidermal gro…

Breast CancerBreast NeoplasmsBreast Cancers

Estimated

~$10 – $7,500

Baylor Research InstituteNCT06517212

Phase 4

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group o…

Wound ClosureBrain Tumor AdultSpine+3 more

Estimated

~$10 – $6,250

University of MichiganNCT07225101

Pilot Trial to Identify microRNAs in Cachexia in Patients With Pancreatic Carcinoma

The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the…

Resectable Pancreatic Adenocarcinoma

Estimated

~$10 – $750

University of OklahomaNCT05275075

Phase 2

Effects of TNF Blockade on Human BPH/LUTS

Specific Aim 1. To evaluate the efficacy of TNF antagonist action in BPH/LUTS Specific Aim 2. Define the consequences of TNF antagonist therapy on prostate tis…

Benign Prostatic Hyperplasia (BPH)

Estimated

~$10 – $7,500

Endeavor HealthNCT06062875

Personalized Models for Cancer Research

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to perso…

Solid Tumor, Adult

Estimated

~$10 – $750

New York Stem Cell Foundation Research InstituteNCT06350539